• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    FibroBiologics, Inc. - Common Stock (NQ: FBLG )

    2.250 +0.220 (+10.84%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 224,056
    Open 2.030
    Bid (Size) 2.000 (1)
    Ask (Size) 2.300 (61)
    Prev. Close 2.030
    Today's Range 2.020 - 2.290
    52wk Range 1.078 - 55.00
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly
    From Fibrobiologics, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -92.27%
    -92.27%
    1 Month
    -6.64%
    -6.64%
    3 Month
    -18.48%
    -18.48%
    6 Month
    -55.00%
    -55.00%
    1 Year
    -92.27%
    -92.27%

    More News

    Read More
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics
    From Fibrobiologics, Inc.
    Via GlobeNewswire
    FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
    From Fibrobiologics, Inc.
    Via GlobeNewswire
    This NANO Nuclear Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
    Via Benzinga
    FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology
    From Fibrobiologics, Inc.
    Via GlobeNewswire
    FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024
    From Fibrobiologics, Inc.
    Via GlobeNewswire
    FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases
    From Fibrobiologics, Inc.
    Via GlobeNewswire
    FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office
    From Fibrobiologics, Inc.
    Via GlobeNewswire
    FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit
    From Fibrobiologics, Inc.
    Via GlobeNewswire
    FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa
    From Fibrobiologics, Inc.
    Via GlobeNewswire
    FibroBiologics Engages Southern Star Research as CRO in Australia
    From Fibrobiologics, Inc.
    Via GlobeNewswire
    FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology
    From Fibrobiologics, Inc.
    Via GlobeNewswire
    FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
    From Fibrobiologics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology
    From Fibrobiologics, Inc.
    Via GlobeNewswire
    FibroBiologics Files 2024 Second Quarter Report
    From Fibrobiologics, Inc.
    Via GlobeNewswire
    FibroBiologics to Present at JonesTrading Healthcare Summit 2024
    From Fibrobiologics, Inc.
    Via GlobeNewswire
    FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology
    From Fibrobiologics, Inc.
    Via GlobeNewswire
    FibroBiologics Set to Join Russell 2000® Index
    From Fibrobiologics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Vail Resorts Posts Downbeat Q3 Results, Joins Concrete Pumping, DocuSign And Other Big Stocks Moving Lower In Friday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024
    From Fibrobiologics, Inc.
    Via GlobeNewswire
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.